# RxVigilance — Drug decision assistant

> Canadian drug decision assistant for healthcare professionals. (iPhone/iPad app by Vigilance Sante Inc..)

- Source: https://appshunter.io/ios/app/rxvigilance/id6741224580 (this page in markdown: same URL + `.md`)
- Developer: [Vigilance Sante Inc.](https://appshunter.io/developer/1166663773)
- Category: Medical, Productivity
- Price: Free
- Rating: 4.80/5 from 5 App Store ratings
- Age rating: 17+
- Requires: iOS 17 · 61 MB
- Languages: American English
- Released: 2025-03-04
- Data updated: 2026-08-21
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/rxvigilance/id6741224580/reviews.md

## What is RxVigilance?

RxVigilance is a must-have tool for healthcare teams across Canada, specially designed to facilitate informed and reliable clinical decision-making regarding medications. This Canadian software can be accessed anytime, anywhere by downloading the iOS app for iPad® or iPhone®.

Adopted by over 50,000 users, this reference and analysis software offers clear, up-to-date and essential drug information, adapted to the daily needs of any type of practice. Whether you are assessing drug interactions, consulting summary monographs or analyzing drugs with the help of comparative tables, RxVigilance is an indispensable ally.


iPad and iPhone are trademarks of Apple Inc, registered in the US and other countries.

**RxVigilance usage license required**

## Key features

- Informed clinical decision-making
- Drug interaction assessment
- Summary drug monographs
- Comparative drug analysis
- Up-to-date drug information
- Accessible on iOS devices


## Frequently asked questions about RxVigilance

### What is RxVigilance?

RxVigilance is a Canadian medical application designed to assist healthcare teams in making informed decisions about medications. It offers access to clear, up-to-date drug information, including interaction assessments and comparative analyses.

### Who is RxVigilance for?

This app is specifically designed for healthcare teams across Canada, including doctors, pharmacists, and nurses, who require reliable drug information for their daily practice.

### What devices does RxVigilance support?

RxVigilance is available for iOS devices, including iPhone, iPad, and iPod. It is optimized for use on these Apple platforms.

### How often is RxVigilance updated?

The latest version of RxVigilance is 2026.4.0, and it was last updated on April 14, 2026. This indicates a commitment to providing current information.

### What is the user rating for RxVigilance?

RxVigilance has a strong user rating of 4.8 stars based on 5 ratings, suggesting a high level of user satisfaction with its functionality and reliability.

### Does RxVigilance have ads?

No, RxVigilance does not contain advertisements. The application is free to download and use without interruptions from ads.

### What is the age rating for RxVigilance?

RxVigilance has an age rating of 17+. This is typical for medical reference applications that contain detailed pharmacological information.

### Is RxVigilance available outside of Canada?

While RxVigilance is designed for healthcare teams across Canada and references Canadian drug information, its availability on the iOS App Store may extend to other regions. However, its primary focus is the Canadian market.

## Version history (last 5 releases)

### 2026.8.0 — 2026-08-18

Performance and stability improvements

### 2026.6.0 — 2026-06-12

Performance and stability improvements

### 2026.4.0 — 2026-04-14

Performance and stability improvements

### 2026.3.0 — 2026-03-11

Performance and stability improvements

### 2026.2.0 — 2026-02-16

Performance and stability improvements

## More apps by Vigilance Sante Inc.

- [RxVigilance Mobile](https://appshunter.io/ios/app/rxvigilance-mobile/id1166663774)

All apps by Vigilance Sante Inc.: https://appshunter.io/developer/1166663773

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-08-21.*